Xiao-fei Zhang
12 Urumqi Road
Shanghai, 200040, China
Shanghai, 200040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Prospective population pharmacokinetic study of tacrolimus in adult recipients early after liver transplantation: A comparison of Michaelis-Menten and theory-based pharmacokinetic models.
Journal: Frontiers in pharmacology
Published: August 30, 2022
Targeting mTORC1/2 Complexes Inhibit Tumorigenesis and Enhance Sensitivity to 5-Flourouracil (5-FU) in Hepatocellular Carcinoma: A Preclinical Study of mTORC1/2-Targeted Therapy in Hepatocellular Carcinoma (HCC).
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: May 04, 2018
microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma.
Journal: OncoTargets and therapy
Published: May 03, 2018
Erratum to Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients.
Journal: Cancer biology & medicine
Published: April 27, 2017
Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients.
Journal: Cancer biology & medicine
Published: February 04, 2017
GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis.
Journal: Cancer cell
Published: February 09, 2014
MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.
Journal: Hepatology (Baltimore, Md.)
Published: September 09, 2013
MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
Journal: Hepatology (Baltimore, Md.)
Published: September 18, 2012
microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma.
Journal: International journal of molecular medicine
Published: June 01, 2012
Last Updated: 09/26/2026